Sectral and Hair loss - a phase IV clinical study of FDA data

Summary:

Hair loss is reported as a side effect among people who take Sectral (acebutolol hydrochloride), especially for people who are female, 60+ old, also take Vitamin E, and have Herpes zoster.

The phase IV clinical study analyzes which people have Hair loss when taking Sectral. It is created by eHealthMe based on reports of 3,508 people who have side effects when taking Sectral from the FDA, and is updated regularly.

What is Sectral?

Sectral has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,548 Sectral users. Check the latest studies of Sectral.

What is Hair loss?

Hair loss is found to be associated with 2,411 drugs and 3,513 conditions by eHealthMe. Check the latest studies of Hair loss.

On Jul, 19, 2026

3,508 people reported to have side effects when taking Sectral.
Among them, 25 people (0.71%) have Hair loss.

Among these 25 people:

What is the gender of people who have Hair loss when taking Sectral? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Hair loss when taking Sectral? *

What are other drugs people take besides Sectral? *

What are other side effects people have besides Hair loss? *

Weight Decreased: 3 people, 12.00%
Tooth Disorder (tooth disease): 3 people, 12.00%
Loose Tooth: 3 people, 12.00%
Drug Ineffective: 3 people, 12.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 12.00%
Chest Pain: 3 people, 12.00%
Stress And Anxiety: 3 people, 12.00%
Headache (pain in head): 3 people, 12.00%
Tooth Fracture: 3 people, 12.00%
Depression: 2 people, 8.00%

What are the existing conditions these people have? *

Stress And Anxiety: 3 people, 12.00%
Herpes Zoster: 3 people, 12.00%
Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 1 person, 4.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.00%
Pain: 1 person, 4.00%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 1 person, 4.00%
Itching: 1 person, 4.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.00%
Birth Control: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sectral and have Hair loss?

- Check whether Hair loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sectral:

Sectral (3,548 reports)

Hair loss treatments and more:

Hair loss (271,201 reports)

Browse all side effects of Sectral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hair loss:

Hair loss (2,411 drugs)

Browse all the conditions that are associated with Hair loss:

Hair loss (3,513 conditions)

Related publications that referenced our studies

Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride (the active ingredients of Sectral) and Sectral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.